Pair Name | Sulforaphane, PR-104A | ||
Phytochemical Name | Sulforaphane (PubChem CID: 5350 ) | ||
Anticancer drug Name | PR-104A (PubChem CID: 9848786 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Sulforaphane, PR-104A | |||
Disease Info | [ICD-11: 2B90] | Colon cancer | Investigative | |
Gene Regulation | Up-regulation | Expression | AKR1C3 | hsa8644 |
In Vitro Model | HT-29 | Colon adenocarcinoma | Homo sapiens (Human) | CVCL_0320 |
SW620 | Colon adenocarcinoma | Homo sapiens (Human) | CVCL_0547 | |
Result | The enhanced response of PR-104A after preconditioning with SF was apparent only in cancer cells provided that AKR1C3 is expressed, while its expression in non-cancerous cells did not elicit such a response. Therefore, a subset of cancers may be susceptible to combined food-derived component and prodrug treatments with no harm to normal tissues. |
No. | Title | Href |
---|---|---|
1 | Sulforaphane Preconditioning Sensitizes Human Colon Cancer Cells towards the Bioreductive Anticancer Prodrug PR-104A. PLoS One. 2016 Mar 7;11(3):e0150219. doi: 10.1371/journal.pone.0150219. | Click |